-
Pfizer's 2025 Outlook: Moderate Stability or Volatility Ahead?
- 2025/01/11
- 再生時間： 2 分
- ポッドキャスト
-
サマリー
あらすじ・解説
Pfizer's stock price as of January 8, 2025, is $26.86[1]. The current price is below the 52-week high of $31.54 and above the 52-week low of $24.48, indicating a moderate position within its recent trading range.
Recent trading volume data is not provided in the available sources, but it is crucial to consider this factor for a comprehensive analysis. Typically, high trading volumes compared to the average can indicate significant investor interest or potential volatility.
There are no recent news or announcements about Pfizer or its stock mentioned in the provided sources. However, analyst updates and price target changes are available. The consensus price target among analysts is $32.00, with a forecasted upside of 18.87% from the current price[2]. Some analysts, such as Truist Securities, have set a price target of $32.00, expecting a 19.54% upside within the next 12 months[3].
Other forecasts vary significantly. CoinPriceForecast predicts a price range of $31.12 to $31.61 in 2025, indicating steady growth[4]. In contrast, PandaForecast anticipates a broader range of $26.46 to $40.15, with significant increases throughout the year[4]. LongForecast provides a detailed monthly forecast for 2025, starting with a range of $24.20 to $29.21 in January and ending with a range of $35.69 to $41.89 in December[5].
In summary, Pfizer's stock is currently trading at $26.86, with analysts predicting a potential upside of 18.87% to $32.00. Various forecasts suggest a range of possible outcomes, from steady growth to significant increases throughout 2025. Investors should consider these predictions along with recent trading volumes and any upcoming news or announcements for a comprehensive understanding of Pfizer's stock performance.
Recent trading volume data is not provided in the available sources, but it is crucial to consider this factor for a comprehensive analysis. Typically, high trading volumes compared to the average can indicate significant investor interest or potential volatility.
There are no recent news or announcements about Pfizer or its stock mentioned in the provided sources. However, analyst updates and price target changes are available. The consensus price target among analysts is $32.00, with a forecasted upside of 18.87% from the current price[2]. Some analysts, such as Truist Securities, have set a price target of $32.00, expecting a 19.54% upside within the next 12 months[3].
Other forecasts vary significantly. CoinPriceForecast predicts a price range of $31.12 to $31.61 in 2025, indicating steady growth[4]. In contrast, PandaForecast anticipates a broader range of $26.46 to $40.15, with significant increases throughout the year[4]. LongForecast provides a detailed monthly forecast for 2025, starting with a range of $24.20 to $29.21 in January and ending with a range of $35.69 to $41.89 in December[5].
In summary, Pfizer's stock is currently trading at $26.86, with analysts predicting a potential upside of 18.87% to $32.00. Various forecasts suggest a range of possible outcomes, from steady growth to significant increases throughout 2025. Investors should consider these predictions along with recent trading volumes and any upcoming news or announcements for a comprehensive understanding of Pfizer's stock performance.